Search form

Search

Log in

Program for ADHD and Related Conditions (PARC)

Navigation

Home
Team
Treatment Studies
Programs
For Parents
ADHD Clinic
News
Contact

FDA permits marketing of first medical device for treatment of ADHD

April 19, 2019

FDA permits marketing of first medical device for treatment of ADHD

News

03/15/2023 ChildNEXUS Podcast

02/08/2023 APSARD Talk on Nerve- and Neuro- Stimulation Treatments for ADHD

08/02/2022 ADHD - Causes, Treatments, and the Relation to Substance Abuse

07/11/2022 Read about the effect of ADHD medications on sleep

07/04/2022 Read about the key themes and trends in ADHD from 1990 until now

06/13/2022 The effect of the COVID-19 pandemic on children with ADHD and their parents

02/07/2022 Differences in brain structures in ADHD

02/04/2022 Read about emotion regulation and teenagers with ADHD during the COVID-19 pandemic

09/16/2021 What do we know about ADHD? Read more to find out

04/08/2021 A randomized controlled study: online parenting intervention vs. staff intervention for disruptive behavior

02/03/2021 Genetic association between ADHD and cognitive impairments

01/22/2021 NeuroSigma obtains HCPCS codes from CMS for eTNS system

Pages

1
2
3
next ›
last »

Research | Health | Wellness | Privacy Notice | About

Disclaimer: The statements on this page represent the views of the UCLA Semel Institute for Neuroscience and Human Behavior and do not necessarily represent the views of the University of California, or UCLA or its Chancellor. Privacy & Term

© 2024 UCLA Jane & Terry Semel Institute for Neuroscience & Human Behavior

760 Westwood Plaza, Los Angeles, CA 90095

UCLA | Health System | School of Medicine